Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming

Diabetic rats are more immobile during the forced-swimming test (FST) and GABAergic drugs reverse this behavior. We investigated if there is in vivo changes of GABA levels of diabetic rats during the FST. In vivo basal striatal GABA levels of streptozotocin diabetic rats are similar to non-diabetic rats. Non-diabetic rats presented a significant increase in GABA levels after the FST while the increase was delayed and lower in diabetic rats. These results suggest that diabetes may change GABA homeostasis and modify behavioral responses in an animal model of depression.

[1]  F. Petty GABA and mood disorders: a brief review and hypothesis. , 1995, Journal of affective disorders.

[2]  H. Barros,et al.  Ethopharmacology of the Antidepressant Effect of Clonazepam in Diabetic Rats , 2000, Pharmacology Biochemistry and Behavior.

[3]  V. Molina,et al.  Altered behavioral and neurochemical response to stress in benzodiazepine-withdrawn rats , 1996, Brain Research.

[4]  J. Phillis,et al.  The Effect of Streptozotocin-induced Diabetes on the Release of Excitotoxic and Other Amino Acids from the Ischemic Rat Cerebral Cortex , 2001, Neurosurgery.

[5]  Catarina Resende de Oliveira,et al.  Effect of Oxidative Stress on the Uptake of GABA and Glutamate in Synaptosomes Isolated from Diabetic Rat Brain , 2000, Neuroendocrinology.

[6]  R. Clouse,et al.  Depression in Adults with Diabetes , 1992, Diabetes Care.

[7]  W. Drevets Neuroimaging studies of mood disorders , 2000, Biological Psychiatry.

[8]  R. Porsolt,et al.  Depression: a new animal model sensitive to antidepressant treatments , 1977, Nature.

[9]  L. Yatham,et al.  GABA function in mood disorders: an update and critical review. , 1998, Life sciences.

[10]  R. Gerner,et al.  CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. , 1981, The American journal of psychiatry.

[11]  A. Meli,et al.  On the role of endogenous GABA in the forced swimming test in rats , 1988, Pharmacology Biochemistry and Behavior.

[12]  J. Kelly,et al.  The olfactory bulbectomized rat as a model of depression: an update. , 1997, Pharmacology & therapeutics.

[13]  G. Baker,et al.  Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum. , 2002, Biochemical pharmacology.

[14]  L. Hilakivi-Clarke,et al.  Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression , 1990, Physiology & Behavior.

[15]  R. Clouse,et al.  Prevalence of Depression in Adults With Diabetes: An epidemiological evaluation , 1993, Diabetes Care.

[16]  S. McElroy,et al.  The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. , 2002, Journal of affective disorders.

[17]  R. Quirion,et al.  Antidepressant--anxiolytic interaction: decreased density of benzodiazepine receptors in rat brain following chronic administration of antidepressants. , 1984, European journal of pharmacology.

[18]  S. Morishita,et al.  Clonazepam as a therapeutic adjunct to improve the management of psychiatric disorders. , 1998, Psychiatry and clinical neurosciences.

[19]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[20]  G. Biessels,et al.  Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task , 2001, Behavioural Brain Research.

[21]  J. Krystal,et al.  Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. , 2002, The American journal of psychiatry.

[22]  L. Bellush,et al.  The functional significance of biochemical alterations in streptozotocin-induced diabetes , 1991, Physiology & Behavior.

[23]  Y. Claustre,et al.  Fengabine, a novel antidepressant GABAergic agent. II. Effect on cerebral noradrenergic, serotonergic and GABAergic transmission in the rat. , 1987, The Journal of pharmacology and experimental therapeutics.